Intradermal capsaicin causes dose-dependent pain, allodynia, and hyperalgesia in humans

Journal of Investigative Medicine

Volumn 54, Issue 5, 2006, Pages 238-244

  Scanlon, Graham C ^a   Wallace, Mark S ^a   Ispirescu, J Sorin ^a   Schulteis, Gery ^a  

^a University of California   (United States)

Author keywords

Allodynia; Capsaicin; Human pain model

Indexed keywords

CAPSAICIN;

ADULT; ALLODYNIA; ANALGESIA; ARTICLE; CONFOUNDING VARIABLE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERALGESIA; MALE; MEASUREMENT; NORMAL HUMAN; PAIN; PAIN ASSESSMENT; QUANTITATIVE ANALYSIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; VISUAL ANALOG SCALE;

EID: 33845901493     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/6650.2006.05046     Document Type: Article

References (34)

1. LaMotte RH, Lundberg LE, Torebjörk E. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J Physiol 1992;448:749-64.
2. Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997;389:816-24.
3. Tominaga M, Caterina MJ, Malmberg AB, et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998;21:531-43.
4. Greenspan JD, McGillis SLB. Stimulus features relevant to the perception of sharpness and mechanically evoked cutaneous pain. Somatosens Mot Res 1991;8:137-47.
5. Torebjörk E, Lundberg LE, LaMotte RH. Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiol 1992;448:765-80.
6. Park KM, Max MB, Robinovitz E, et al. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects. Pain 1995;63:163-72.
7. Woolf CJ, Bennett GJ, Doherty M, et al. Towards a mechanism-based classification of pain? Pain 1998;77:227-9.
8. Sieweke N, Birklein F, Riedl B, et al. Patterns of hyperalgesia in complex regional pain syndrome. Pain 1999;80:171-7.
9. Petersen KL, Fields HL, Brennum J, et al. Capsaicin evoked pain and allodynia in post-herpetic neuralgia. Pain 2000;88:125-33.
10. Jensen TS, Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 2003;102:1-8.
11. Hughes A, Macleod A, Growcott J, Thomas I. Assessment of the reproducibility of intradermal capsaicin as a model for inducing human pain. Pain 2002;99:323-31.
12. Eisenach JC, Hood DD, Curry R. Preliminary efficacy of intrathecal injection of an American formulation of adenosine in humans. Anesthesiology 2002;96:29-34.
13. Eisenach JC, Hood DD, Curry R. Intrathecal, but not intravenous, clonidine reduces experimental thermal or capsaicin-induced pain and hyperalgesia in normal volunteers. Anesth Analg 1998;87:591-6.
14. Eisenach JC, Hood DD, Curry R, Tong C. Alfentanil, but not amitriptyline, reduces pain, hyperalgesia, and allodynia from intradermal injection of capsaicin in humans. Anesthesiology 1997;86:1279-87.
15. Wallace MS, Ridgeway B, Leung A, et al. Concentration-effect relationships for intravenous alfentanil and ketamine infusions in human volunteers: effects upon acute thresholds and capsaicin-evoked hyperpathia. J Clin Pharmacol 2002;42:70-80.
16. Sang CN, Hostetter MP, Gracely RH, et al. AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans. Anesthesiology 1998;89:1060-7.
17. Gottrup H, Juhl G, Kristensen AD, et al. Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia. Anesthesiology 2004;101:1400-8.
18. Gottrup H, Hansen PO, Arendt-Nielson L, Jensen TS. Differential effects of systemic administration ketamine and lidocaine on dynamic and static hyperalgesia induced by intradermal capsaicin in humans. Br J Anaesth 2000;84:155-63.
19. Wallace MS, Laitin S, Licht D, Yaksh TL. Concentration-effect relations for intravenous lidocaine infusions in human volunteers: effect on acute sensory thresholds and capsaicin-evoked hyperpathia. Anesthesiology 1997;86:1262-72.
20. Wallace MS, Grubbs D. Effects of oral desipramine on capsaicin induced hyperalgesia. Anesth Analg 2002;95:973-8.
21. Wallace MS, Quessy S, Schulteis G. Lack of effect of two oral sodium channel antagonists, lamotrigine and 4030W92, on intradermal capsaicin-induced hyperalgesia model. Pharmacol Biochem Behav 2004;78:349-55.
22. Ando K, Wallace MS, Schulteis G, Braun J. Neurosensory finding after oral mexiletine in healthy volunteers. Reg Anesth Pain Med 2000;25:468-74.
23. Simone DA, Ngeow JYF, Putterman GJ, LaMotte RH. Hyperalgesia to heat after intradermal injection of capsaicin. Brain Res 1987;48:674-8.
24. Simone DA, Baumann TK, LaMotte RH. Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain 1989;38:99-107.
25. Baumann TK, Simone DA, Shaine CN, LaMotte RH. Neurogenic hyperalgesia: the search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia. J Neurophysiol 1991;66:212-27.
26. Gee MD, Lynn B, Cotsell B. The relationship between cutaneous C fibre type and antidromic vasodilation in the rabbit and the rat. J Physiol 1997;503:31-44.
27. Kalman S, Linderfalk C, Wardell K, et al. Differential effect on vasodilation and pain after intradermal capsalcin in humans during decay of intravenous regional anesthesia with mepivacaine. Reg Anesth Pain Med 1998;23:402-8.
28. Lin Q, Zou X, Fang L, Willis WD. Sympathetic modulation of acute cutaneous flare induced by intradermal injection of capsaicin in anesthetized rats. J Neurophysiol 2003;89:853-61.
29. Sumikura H, Andersen OK, Drewes AM, Arendt-Nielsen L. Spatial and temporal profiles of flare and hyperalgesia after intradermal capsaicin. Pain 2003;105:285-91.
30. LaMotte RH, Shaine CN, Simone DA, Tsai EFP. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. J Neurophysiol 1991;66:190-211.
31. Ali Z, Meyer RA, Campbell JN. Secondary hyperalgesia to mechanical but not heat stimuli following a capsaicin injection in hairy skin. Pain 1996;68:401-11.
32. Witting N, Svensson P, Arendt-Nielsen L, Jensen TS. Repetitive intradermal capsaicin: differential effect on pain and areas of allodynia and punctuate hyperalgesia. Somatosens Mot Res 2000;17:5-12.
33. Jensen TS, Gottrup H, Kasch H, et al. Has basic research contributed to chronic pain treatment? Acta Anaesth Scand 2001;45:1128-35.
34. Liu M, Max MB, Robinovitz E, et al. The human capsaicin model of allodynia and hyperalgesia: sources of variability and methods for reduction. J Pain Symptom Manage 1998;16:10-20.